India, Jan. 24 -- Monash University researchers are part of a US-led team working together to develop the first imaging agents that could transform the way lymphatic-related diseases are diagnosed and treated.
The project is being led by the University of Pennsylvania (UPenn) in collaboration with the Monash Institute of Pharmaceutical Sciences (MIPS) and is being backed by a USD$7.8M (~AUD$11.8M)LIGHTgrant from theAdvanced Research Projects Agency for Health(ARPA-H).
The digestive lymphatic system plays a pivotal role in most primary lymphatic diseases, as well as lymphatic related diseases such as tissue swelling (lymphedema), fluid build-up in the abdomen (ascites) from heart or liver disease, and protein loss disorders.
Despite its i...